☆ 4.7 Article

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients

JOURNAL OF PERSONALIZED MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

Psychosocial factors partially explain gender differences in health-related quality of life in heart failure patients

Javier Tapia et al.

Summary: This study aimed to evaluate the influence of gender on quality of life in heart failure. The findings showed that female patients had worse global, physical, and emotional quality of life compared to male patients, but better social quality of life. The differences in quality of life between genders can be partially explained by the interaction between biological and psychosocial factors.

ESC HEART FAILURE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

Theresa A. McDonagh et al.

Summary: All experts involved in the development of the guidelines have declared their interests, and the declarations have been compiled and published in a supplementary report. The report can be accessed on the ESC website. The supplementary data provide background information and detailed discussion of the data that form the basis for the guidelines.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The relationship between self-care, long-term mortality, and heart failure hospitalization: insights from a real-world cohort study

Esther Calero-Molina et al.

Summary: In patients with chronic heart failure, poor self-care is shown to be an independent predictor of long-term mortality (both all-cause and cardiovascular), heart failure hospitalization, and the combination of these endpoints. Crucial dimensions of self-care such as autonomy-based adherence and consulting behavior also determine the risk of these outcomes over time.

EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING (2022)

添加到收藏夹

Review Medicine, General & Internal

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology

Ridha I. S. Alnuwaysir et al.

Summary: Iron deficiency is a common comorbidity in heart failure patients and can have negative effects on exercise capacity, quality of life, hospitalization rates, and mortality risks. Intravenous iron correction has shown promising results in improving symptoms and reducing hospitalizations in heart failure patients. However, the underlying pathophysiology of iron deficiency in heart failure is still poorly understood.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Nursing

Interplay between psychosocial and heart failure related factors partially explains limitations in self-care in patients with heart failure:insights from a real-world cohort of 1,123 patients

E. Calero-Molina et al.

Summary: The self-care behavior of patients with heart failure is influenced by clinical and psychosocial factors. Low social support, absence of caregiver support, and depressive symptoms are the main factors contributing to impaired self-care. It is important to assess and intervene in self-care in patients with heart failure by conducting comprehensive psychosocial assessments.

INTERNATIONAL JOURNAL OF NURSING STUDIES (2022)

添加到收藏夹

Article Health Care Sciences & Services

Do patient-reported outcome measures measure up? A qualitative study to examine perceptions and experiences with heart failure proms among diverse, low-income patients

Jonathan Davis et al.

Summary: In a study conducted in an urban safety-net setting, patients with heart failure generally accepted the KCCQ-12 but felt that it did not adequately measure key health components such as mental health and social relationships that impact their disease management. Further research on incorporating social determinants of health into Patient-Reported Outcome Measures (PROMs) could improve their utility in diverse and underserved populations managing heart failure.

JOURNAL OF PATIENT-REPORTED OUTCOMES (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials

Stephan von Haehling et al.

Summary: The focus of large-scale trials in chronic heart failure has been on evaluating treatments in terms of hospitalizations and mortality, but improving exercise capacity and quality of life for patients with heart failure is also important. Current evidence shows limited effects of treatments on exercise capacity and quality of life, with further studies needed to better understand the effectiveness of these interventions.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality

Radoslaw Sierpinski et al.

Summary: The study identified serum sTfR as the most accurate iron biomarker for diagnosing ID in the bone marrow of patients with HF, and demonstrated its prognostic value in predicting 3-year mortality.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Iron deficiency in heart failure-time to redefine

Pieter Martens et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prognostic role of transferrin saturation in heart failure patients

Jeness Campodonico et al.

Summary: In patients with heart failure, anemia is associated with poor prognosis. Patients with TSAT <20% have worse prognosis compared to those with TSAT >= 20%, and patients with ferritin between 100 and 300 ug/L and TSAT <20% likely have the poorest survival rate.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials

Fraser J. Graham et al.

Summary: Intravenous iron therapy for heart failure patients can significantly reduce the risk of first heart failure hospitalization or cardiovascular mortality. The effect of intravenous iron on heart failure hospitalizations is significant, while the impact on cardiovascular mortality needs further investigation.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Blood Differential Gene Expression in Patients with Chronic Heart Failure and Systemic Iron Deficiency: Pathways Involved in Pathophysiology and Impact on Clinical Outcomes

Carles Diez-Lopez et al.

Summary: This study investigated the biological mechanisms between heart failure and iron deficiency and identified potential prognostic biomarkers through blood gene expression patterns. Patients with systemic iron deficiency in heart failure showed lower levels of key genes in blood, which correlated with adverse clinical outcomes.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells

M. Tajes et al.

Summary: Iron deficiency is common in patients with heart failure and is associated with poor outcomes. Activation of neurohormones in heart failure leads to changes in iron homeostasis, reduced intracellular iron levels, and impaired mitochondrial function. This suggests that iron may play a role in the pathophysiology of heart failure.

CELL AND BIOSCIENCE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study

Ewa A. Jankowska et al.

Summary: Patients with heart failure and iron deficiency experience poor health-related quality of life. Treatment with intravenous ferric carboxymaltose results in clinically beneficial effects on HRQoL as early as 4 weeks after treatment initiation, lasting up to 24 weeks.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study

Ewa A. Jankowska et al.

Summary: The study showed that in iron-deficient patients who had stabilized after an episode of acute heart failure, treatment with IV FCM resulted in significant beneficial effects on HRQoL, lasting up to 24 weeks.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction

Valentin G. Hirsch et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

添加到收藏夹

Article Medicine, General & Internal

Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence

Jose Gonzalez-Costello et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study

Henri Weidmann et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

添加到收藏夹

Article Medicine, General & Internal

Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction

Alex Alcaide-Aldeano et al.

JOURNAL OF CLINICAL MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski et al.

LANCET (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Individual income, mortality and healthcare resource use in patients with chronic heart failure living in a universal healthcare system: A population-based study in Catalonia, Spain

Miguel Cainzos-Achirica et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Reduced levels of vasopressin, an independent mechanism in the obesity paradox in patients with chronic heart failure: Insights from the DAMOCLES study

Meritxell Gavalda-Manso et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity?

Pedro Moliner et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Structural and functional abnormalities in iron-depleted heart

Kamil A. Kobak et al.

HEART FAILURE REVIEWS (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Iron Deficiency in Heart Failure An Overview

Stephan von Haehling et al.

JACC-HEART FAILURE (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

6-minute walking test: a useful tool in the management of heart failure patients

Sophia Giannitsi et al.

THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients

Niels Grote Beverborg et al.

CIRCULATION-HEART FAILURE (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function

Martijn F. Hoes et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study

Jose Gonzalez-Costello et al.

BMC CARDIOVASCULAR DISORDERS (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction

Pieter Martens et al.

ACTA CARDIOLOGICA (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effect of Permanent Atrial Fibrillation on Cognitive Function in Patients With Chronic Heart Failure

Maria Coma et al.

AMERICAN JOURNAL OF CARDIOLOGY (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Ischemic aetiology, self-reported frailty, and gender with respect to cognitive impairment in chronic heart failure patients

Maria J. Gonzalez-Moneo et al.

BMC CARDIOVASCULAR DISORDERS (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients

Nuria Farre et al.

EUROPEAN JOURNAL OF HEART FAILURE (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Differences in neurohormonal activity partially explain the obesity paradox in patients with heart failure: The role of sympathetic activation

Nuria Farre et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Estado del hierro en la insuficiencia cardiaca crónica: impacto en síntomas, clase funcional y capacidad de ejercicio submáxima

Cristina Enjuanes et al.

REVISTA ESPANOLA DE CARDIOLOGIA (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

Piotr Ponikowski et al.

EUROPEAN HEART JOURNAL (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Iron deficiency and health-related quality of life in chronic heart failure: Results from a multicenter European study

Cristina Enjuanes et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)

添加到收藏夹

Article Endocrinology & Metabolism

Iron Status and Survival in Diabetic Patients With Coronary Artery Disease

Beata Ponikowska et al.

DIABETES CARE (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study

Josep Comin-Colet et al.

EUROPEAN HEART JOURNAL (2013)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives

Ewa A. Jankowska et al.

EUROPEAN HEART JOURNAL (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status

Josep Comin-Colet et al.

EUROPEAN JOURNAL OF HEART FAILURE (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Myocardial iron homeostasis in advanced chronic heart failure patients

Przemyslaw Leszek et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure

Ewa A. Jankowska et al.

JOURNAL OF CARDIAC FAILURE (2011)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Iron deficiency: an ominous sign in patients with systolic chronic heart failure

Ewa A. Jankowska et al.

EUROPEAN HEART JOURNAL (2010)

添加到收藏夹

Article Medicine, General & Internal

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.

Stefan D. Anker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

Article Hematology

Serum transferrin receptor

Barry S. Skikne

AMERICAN JOURNAL OF HEMATOLOGY (2008)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Validación de la versión española del Minnesota Living with Heart Failure Questionnaire

Olatz Garin et al.

REVISTA ESPANOLA DE CARDIOLOGIA (2008)

添加到收藏夹

Article Urology & Nephrology

Assessing iron status: Beyond serum ferritin and transferrin saturation

Jay B. Wish

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.